LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News NEWS FLASH L impact Sep 24, 2026, 09:55 AM UTC

Praxis Precision Med Price Target Maintained With a $582.00/Share by Needham

Ratings actions

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

PRAX

Related stories

Merck & Co., Inc., Rahway, N.J., USA DME Drug Meets Phase 2b/3 Non-Inferiority Merck said remigromig met the primary endpoint of non-inferiority to 0.5 mg ranibizumab in BCVA at 52 weeks in the pivotal Phase 2b/3 BRUNELLO DME trial; higher rates of PDR, vitre L impact | NEWS | Sep 24, 2026, 10:45 AM UTC BME names Alliance Automotive CEO Franck Baduel to supervisory board BME Group named Franck Baduel to its Supervisory Board. * Baduel is CEO of Alliance Automotive Group, a pan-European automotive spare parts distributor with nearly €4 billion in re L impact | NEWS | Sep 24, 2026, 10:45 AM UTC UPDATE 1 — AI startup Island valued at $6.4 billion in latest funding round (Adds details throughout) Sept 24 (Reuters) — AI startup Island said on Thursday it raised $400 million in a funding round that valued it at $6.4 billion. The Series F funding roun L impact | NEWS | Sep 24, 2026, 10:45 AM UTC MIAX - Miami International Holdings Announces OCC Clearing Membership for its FCM L impact | NEWS | Sep 24, 2026, 10:45 AM UTC Merck’s Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2b/3 BRUNELLO Study of Adults with Diabetic Macular Edema Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal Phase 2b/3 BRUNELLO trial in adults with diabetic macular L impact | NEWS | Sep 24, 2026, 10:45 AM UTC Majority of U.S. Consumers Now Use AI to Shop, NIQ Finds NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced new findings from its Agentic Commerce Tracker showing that 51% of U.S. consumers have used at leas L impact | NEWS | Sep 24, 2026, 10:45 AM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.